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Target genes of ultraviolet stress response in cuta-
neous melanocytes, potentially associated with solar-
induced melanocarcinogenesis, were characterized
by cDNA microarray technology. In cultured normal
human melanocytes, 198 genes out of »9000 arrayed
were found modulated > 1.9 times following arti®-
cial ultraviolet ± mainly ultraviolet-B ± irradiation
(100 mJ per cm2). Among them, 159 corresponded
to known sequences, the encoded proteins being
mostly involved in DNA or RNA binding/synthesis/
modi®cation, or ribosomal proteins. The others were
transcription factors, receptors, tumor suppressors,
and (proto)oncogenes. Members of these families
have already been linked to melanoma. In addition,
some of the modulated genes were borne by
chromosomes harboring candidate melanoma loci.
Comparisons with genes modi®ed in melanoma
samples reported in previous studies with similar
microarray platform showed that 59% of the known
genes sensitive to ultraviolet were modulated in the
same way. Furthermore, 39 expressed sequence tags
were modulated, and preliminary experiments
showed that two expressed sequence tags displayed
differential expressions both in melanoma cell lines
and in melanoma tumors. These results provide a
basis for further studies on the role of modulated
genes in ultraviolet-induced melanoma. Because
some of these genes are potential markers of the dis-
ease, they might help for developing new molecular-
based strategies for risk prediction in patients. Key
words: DNA microarray/melanocyte/melanoma/UV stress.
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P
hotocarcinogenesis is known to be one of the possible
consequences of ultraviolet (UV) irradiation of living
tissues (Black et al, 1997) and epidemiologic studies have
shown that sun exposure is a risk factor for melanoma
development. Once a rare cancer, melanoma frequency
is increasing in the Caucasian white population of developed
countries (Elwood, 1996; Green et al, 1999). Individual genetic
predisposition and exposure to UV from sunlight combine together
and may result in tumoral transformation of cutaneous pigmented
cells, namely the melanocytes. Intermittent acute sun exposure
rather than total dose of exposures seems to play a major role in
induction of melanocarcinogenesis (Elwood, 1996).
Early ®ndings in the 1960s demonstrated that UVB wavelengths
from the total sunlight spectrum could induce skin carcinoma in
mice. Ef®cient wavelengths were identical to those responsible for
high levels of cyclobutane pyrimidine dimers in DNA, whose
incorrect repair leads to mutations (de Gruijl and Forbes, 1995; de
Gruijl, 1999). Importantly, a data treatment from mice studies
allowed their extrapolation to humans (de Gruijl, 1999). Much
subsequent biochemical and clinical evidence strengthened the role
of UVB in genetic instability and protein dysfunction that
contribute to nonmelanoma and melanoma skin cancers. In
addition, because UVB radiation is also the primary inducer of
sunburn, which has been identi®ed as a risk factor for melanoma,
UVB wavelengths have been mostly implicated in melanocarcino-
genesis. On the other hand, more recent evidence from animal
model studies (Setlow et al, 1993; Wang et al, 2001) and from a
growing set of in vitro investigations has highlighted the role of
UVA in melanoma etiology. UVA radiation is known to induce
oxidative mutagenic DNA base damage, oxidative cell stress, and,
like UVB, immunosuppression, which plays a recognized role in
melanoma development (Black et al, 1997; Grether-Beck et al,
1997; Stary et al, 1997). Discrepancies are sometimes observed
among data from different animal models (especially Monodelphis
opossums versus Xiphophorus ®shes) and UVA-induced precursor
lesions do not always cause conversion to malignancy (Lei, 1997;
Robinson et al, 2000). Although the contributive role of UVA is
forewarned and an epidemiologic support exists (Moan et al, 1999),
evidence from epidemiologic studies and clinical observations on
humans are still inconclusive (Wang et al, 2001). Yet, if additional
in vitro investigations are required, it is rather dif®cult to use
biologically ef®cient UVA irradiation times while respecting cell
culture conditions. By contrast, the major role of UVB in
melanoma development is clinically recognized and UVB cell
irradiation is quite short. This is why we chose in this study to
establish the list of human melanocyte genes undergoing a
modi®cation of their expression upon an arti®cial UV irradiation
composed mainly of UVB wavelengths.
At the molecular level, the effects of UVB stress on melanocytes
are still poorly understood, as most studies in various cell types have
focused on the mutagenic, DNA-damaging and cell-cycle-disturb-
ing actions of UV-C. More than 50 genes are presently known to
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participate in UV stress response in mammalian cells (Trautinger et
al, 1996; Piepkorn, 2000a) and some of them may be speci®c to
melanocytes (Ablett et al, 1998). Obviously, not all the known
genes modulated by UVB irradiation are involved in carcinogen-
esis, but many of them re¯ect a partly transformed phenotype
(Friedberg et al, 1995), including malignant melanoma (Friedberg et
al, 1995; Muijen et al, 1995). Other UV-sensitive genes may
participate in cell homeostasis, such as NF-kB, which plays a pivotal
role in immune, in¯ammatory, cell migratory, and growth
responses (Benoliel et al, 1997; Legrand-Poels et al, 1998). As no
less than 6000 transcripts have been identi®ed in Soares melanocyte
cultures (2NbHM) (URL: http://www.ncbi.nlm.nih.gov/
UniGene/index.html) their stepwise analysis is obviously irrealistic.
An optimal approach would be to systematically select genes whose
expression is modi®ed in response to UV stress for further studies.
This is now feasible, using the DNA microarray technology
(DeRisi et al, 1996; Loftus and Pavan, 2000). This technology
involves spotting thousands of ordered cDNA probes (clones) on a
solid support and, in our case, hybridizing the array with two
labeled cDNA populations obtained from reverse transcription of
mRNA samples collected from normal or UV-stressed melano-
cytes. Quanti®cation of label signals from hybridized support gives
the expression pro®ling and function-relation assignment of known
and unknown genes. The latter are identi®ed because ``expressed
sequence tag'' (EST) clones are also arrayed on the solid support.
These mRNA sequences are organized in clusters and correspond
to putative new genes, although several EST can be derived from
the same RNA transcript.
This study is the ®rst application of a DNA microarray to the
screening of more than 9000 genes from cutaneous normal human
melanocytes (NHM) exposed to an acute UV ± mainly UVB ±
stress, compared to sham-irradiated counterparts. Approximately
30% of the human genome is thus explored and data are compared
to previous data on the expression of known genes in melanoma. In
addition, we report preliminary results on the expression of some
selected UV-modulated EST in melanoma cell lines and tumors.
MATERIALS AND METHODS
Cell culture, cell treatment, RNA extraction NHM were obtained
from infant foreskins and pure melanocyte cultures were settled as
already described (ValeÂry et al, 2001). Cell samples from several donors
were pooled to cancel interindividual variations. Although control and
irradiated cells were from the same culture batch, phorbol 12-myristate
13-acetate (PMA) was removed 72 h before UV irradiation to avoid
possible drug-induced differences in gene expression. At the day of
experiment, half of the culture (passage 4) received a radiometric-
calibrated (four measures per second), computer-assisted UV irradiation
at a ¯uence of 100 6 0.001 mJ per cm2, which was performed with a
Bio-Sun apparatus (Vilber Lourmat, Marne-la-ValleÂe, France). Four UV
lamps (ref. T-20.M, 20 W low pressure Hg lamp) delivered an irradiance
of 0.91 6 0.01 mW per cm2 at 312 nm. The spectral irradiance of the
UV source is given in Fig 1, which shows that energy is mainly emitted
in the UVB wavelengths. During irradiation, cells were covered with a
phosphate-buffered saline ®lm containing magnesium and calcium and
the culture dish lid was removed. The other half of the culture was
sham-irradiated (control). In these conditions, cell viability was >75%,
15 h following UV stress. For the DNA microarray, total RNA was
extracted at 4 h following UV treatment of NHM using the TRIZOL
reagent method (Life Technologies, Cergy Pontoise, France) as
recommended by the manufacturer with a slight modi®cation: an
additional extraction with the ternary solvent phenol:chloroform:isoamyl
alcohol (50:49:1) was performed before the RNA precipitation step.
SK-MEL-2 (ATCC cat. HTB-68, Manassas, VA) melanoma cell line
was cultured in modi®ed Eagle's medium (Sigma, St. Louis, MO),
whereas KAL (Cohen-Knafo et al, 1995) and M3Dau (Jacubovich et al,
1985) cell lines were cultured in RPMI medium. HBL melanoma cell
line (Del Marmol et al, 1996) was grown in MCDB153 medium. All
media contained 10% fetal bovine serum, without antibiotics. These
melanotic cell lines were chosen because they induce melanoma tumor
formation after injection into nude mice (KAL, M3Dau, SK-MEL-2),
possess both eumelanogenesis and phaeomelanogenesis pathways (HBL),
and originate from metastases located at various sites, such as lymph
nodes and thigh. For reverse transcription polymerase chain reaction
(RT-PCR) experiments, total RNA was extracted from cell lines and
NHM with the GenElute Mammalian Total RNA kit (Sigma).
Equivalent amounts of total RNA, evaluated by optical density at
260 nm, were used for reverse transcription of mRNA and ampli®ed by
PCR.
Melanoma tumors Primary and secondary cutaneous melanoma
tumors as well as metastatic tumors located in patient lymph nodes
(Table I) were snap-frozen in liquid nitrogen. All tumoral tissues were
obtained from patients at the Department of Dermatology, St.
Figure 1. Spectral irradiance of the arti®cial UV source employed
in this study. Irradiance of UV-emitting tubes from the BioSun
apparatus (Vilber-Lourmat, France) is plotted against wavelength.
Table I. Description of melanoma tumor samples used in this study
Sample Tumor type (UICCa stage) Clark's level Breslow's index (mm) Prognosis
T1 Local secondary (II) II 1.5 Quite good. Slow evolution
T2 Lymph node metastasis (III) Bad. Quick evolution
T3 Primary (I) 0.80 Theoretically good
T4 Primary (I) II/III 2 Reserved
T5 Local secondary (II) (multimetastases) III n.p.b Acute in¯ammatory evolution ± deathc
T6 Local secondary (II) n.p.b 4.5 Deathc
T7 Lymph node metastasis (III) Reserved
T8 Lymph node metastasis (III) Reserved
aUICC, Union Internationale Contre le Cancer and American Joint Committee on Cancer.
bn.p., determination not possible.
cDeath occurred during hospitalization.
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Marguerite's Hospital and Institut Paoli-Calmette (Anticancerous Center)
at Marseille, France. Informed consent from living patients was obtained
after agreement of the local committee on ethics. Total RNA used in
RT-PCR was extracted as for cultured cells after homogenization of
tissues with a Konte glass potter.
Microarray technology and probes The DNA microarray device
was settled through collaboration with a private partner. A normalized
cDNA library was used to minimize redundancy. All clones on the
microarray were sequence-veri®ed and carefully mapped to NCBI's
GenBank/UniGene database on 3 April 2000. An update was performed
at the end of this work on 12 March 2001 and the list of clones (name,
GenBank's accession numbers) was modi®ed accordingly. After
ampli®cation, more than 9000 human cDNA clones were deposited on
the solid support through optimized key processes. Thirty percent of
them were EST as de®ned by the GenBank release on 12 March 2001.
cDNA sizes ranged from 500 to 5000 bp, with an average of 1 kb.
Probes were cDNA obtained by standard reverse transcription of mRNA
populations from NHM after either sham irradiation (control) or UV
irradiation of the cells. During the reverse transcription reaction, sham-
irradiated and UVB-irradiated populations of cDNA were labeled,
respectively, with the cyanine dyes Cy3 and Cy5. No ampli®cation
protocol was used on any mRNA sample, ensuring that ampli®cation
artifacts did not affect differential expression (DE) ratios. The microarray
scanning was performed with confocal laser microscopy and
computerized image analysis. The limit of detectable DE was initially set
at 1.75 in our study, but in recent analysis process versions this limit
decreased to 1.4-fold DE. In practice, three different human tissue
sources were used (placenta, heart, and brain). DE precision was
determined by hybridizing samples from all three tissues again themselves
in replicates of 10 on 70 microarrays in two batches. As the mRNA
source in both channels was identical, the expected DE ratio for each
gene was 1:1. Precision of the hybridization was plotted as a histogram
of the natural logarithm of the DE ratios. Each histogram was calculated
from approximately 100,000 points. The distribution of DE ratios was
similar (1:10,000 difference in ratios) for hybridization in each tissue
class, ensuring very good accuracy. For the three sets of tissue
hybridization the limit of detectable DE was estimated using the
statistical tolerance interval approach. Mathematically, the limit of
detectable DE for elements with expected ratios of 1:1 could be
expressed in terms of a two-sided statistical tolerance interval. For the
three tissue sets, the range of DE elements was obtained in the 99%
tolerance intervals, and the limit of detectable DE was based on results
from 30 separate hybridizations. The relative standard deviation (CV)
provided a useful estimate of DE precision. The calculated total DE ratio
CV for all three tissue groups was 12%. Therefore, the limit of DE used
in this study was set at 1.75 6 0.12, keeping in mind that 1.4 6 0.12
DE was already signi®cant.
The dynamic range for probe detection was between 2 and 2000 pg
and signals less than 2.5 times greater than background signal were
rejected. On each microarray a variety of control sequences were arrayed
in quadruplicate, and had minimal homology to any known gene in
order to avoid cross-hybridization with NHM cDNA probes.
RT-PCR reactions Speci®c primers (Genset Oligos, Paris, France)
were designed according to the partial human EST or known gene
sequences (veri®ed with GenBank/UniGene banks and BLAST
alignment procedures at URL: http://www.ncbi.nlm.nih.gov/Sitemap/
index.html). The expected sizes for the two selected EST were 329 bp
for EST 101B (GenBank AA057365) and 420 bp for EST 406A
(GenBank AI972375). The expected sizes for the known genes were
480 bp for serum glucocorticoõÈd regulated kinase (Sk1) and 409 bp for
human ribosomal protein L35 (Hrp). Starting cDNA material was
quantitated using b-actin primers (forward nucleotides 891±912, 5¢-
GCATCCACGAAACTACCTTCA-3¢; reverse nucleotides 1029±1050,
5¢-GCAGTGATCTCCTTCTGCAT-3¢), giving a 159 bp ampli®ed
segment. After reverse transcription of cell and tumor mRNA, the
resulting cDNA were ampli®ed by PCR. For all selected transcripts,
preliminary experiments were carried out to ascertain a linear PCR
ampli®cation range from the starting amount of cDNA. The PCR
consisted of an initial step at 94°C for 2 min followed by 30±35 cycles
(according to starting cDNA amounts): 94°C for 0.5 min; annealing at
55°C or 60°C (according to the primers) for 0.5 min; elongation at
72°C for 1 min. The ®nal elongation was at 72°C for 5 min. Finally,
one-sixth volume of the products was run in a 1% agarose gel containing
0.5 mg per ml ethidium bromide and visualized under UV light. pUC
mix Marker 8 (110±1116 bp, Fermentas AB, Vilnius, Lithuania) was
used as DNA size marker. Densitometry scanning of the gels was
performed with the Easy Image Plus system (Herolab, Wielosch,
Germany) and the analySIS software (Soft Imaging System, Munster,
Germany).
RESULTS
Expression analysis of genes modulated by arti®cial UV
radiation in NHM Single DNA microarray analysis of
transcripts, 4 h following irradiation of NHM by 100 mJ per cm2
arti®cial UV ± mainly UVB ± radiation (spectral irradiance of the
source is given in Fig 1), showed that 198 genes out of »9000
(2.2%) were modulated 1.9 times or more (Table II). That
threshold was chosen to keep a safety margin from the limit of
detectable signi®cant DE (1.75 times, see Materials and Methods).
Maximum variation was 6 and 2.7 times compared to control, for
downregulated and upregulated genes, respectively.
Underexpressed genes accounted for 59.1% (117 clones), whereas
40.9% (81 clones) were overexpressed. Of the 198 modulated
genes, 159 were already known, 88 (44.4%) being underexpressed
and 71 (35.8%) overexpressed. The other 39 were EST, of which
14.6% (29 clones) were underexpressed and 5.0% (10 clones)
overexpressed.
Known genes modulated > 1.9 times, classi®ed according to the
function of encoded proteins, are listed in Table III. For each
category, the percentage of genes modulated > 1.9 times, relative
to the total number of clones in that category spotted on the
microarray, is also given. Genes encoding proteins involved in
binding, synthesis, or modi®cation of DNA or RNA were most
represented among underexpressed known genes (»35%), 45.7%
being zinc-®nger proteins, but accounted for only »4% of
upregulated known genes (three out of 71). By contrast, ribosomal
Table II. DNA microarray results: NHM genes modulated
by UV ± mainly UVB ± stressa
Overexpressed, 81 (40.9%) Underexpressed, 117 (59.1%)
Known EST Known EST
71 (35.8%) 10 (5.0%) 88 (44.4%) 29 (14.6%)
a198 melanocyte genes modulated (2.2% of »9000 total arrayed clones), at a
threshold of DE >1.9 times for transcripts from UV-irradiated cells compared with
sham-irradiated counterparts (control). Percentages relate to total genes modulated.
Figure 2. Chromosomal distribution of the selected known genes
responsive to UV ± mainly UVB ± stress in NHM. The percentages
of underexpressed and overexpressed clones to the total of modulated
known clones (at a threshold > 1.9) were evaluated for each human
chromosome and are reported in this histogram.
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Table III. Classi®cation, according to their function, of genes of known sequence modulated > 1.9 times by UV ± mainly
UVB ± stress in NHM
Function family GenBank accession number DE
UNDEREXPRESSED KNOWN CLONES
DNA/RNA synthesis and modi®cation, 35.2%a, 17.8%b
Zinc ®nger protein 267 AU128446 ±3.4
Hypothetical protein FLJ11191 NM_018355 ±3.1
Zinc ®nger protein 184 (Kruppel-like) AL021918 ±3.0
Kruppel-type zinc ®nger (C2H2) AK023025 ±2.9
Zinc ®nger protein 165 X84801 ±2.8
Transcription factor 17 NM_018355 ±2.8
Zinc ®nger protein 175 D50419 ±2.6
Zinc ®nger protein 266 X78924 ±2.5
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 17 (72 kDa) AW188131 ±2.5
Zinc ®nger protein 195 NM_00715 ±2.3
Zinc ®nger protein 45 (a Kruppel-associated box (KRAB) domain polypeptide) NM_003425 ±2.2
Zinc ®nger protein 177 NM_00345 ±2.2
Translin-associated factor X X95073 ±2.2
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3 AU125885 ±2.2
RNA binding protein; AT-rich element binding factor AC004493 ±2.1
RNA binding motif ± single-stranded interacting protein 1 NM_016836 ±2.1
Zinc ®nger protein 84 (HPF2) NM_00342 ±2.1
Zinc ®nger protein 7 (KOX 4, clone HF.16) M29580 ±2.1
Zinc ®nger protein 273 X78932 ±2.1
Zinc ®nger protein 24 (KOX 17) AF016052 ±2.1
SON DNA binding protein X63071 ±2.0
Polymerase (RNA) III (DNA directed) (39 kDa) AL121893 ±2.0
E74-like factor 1 (ets domain transcription factor) M82882 ±2.0
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 15 AF279891 ±2.0
Chromodomain helicase DNA binding protein 1 AF006513 ±2.0
Zinc ®nger protein 38 (KOX 25) X0729 ±2.0
Hypoxia-inducible factor 1, alpha subunit (basic helix±loop±helix transcription factor) AF207601 ±2.0
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 5 (RNA helicase 68 kDa) X15729 ±2.0
Zinc ®nger protein 211 NM_006385 ±2.0
Zinc ®nger protein 134 (clone pHZ-15) NM_003435 ±2.0
Hypothetical protein P1 p373c6 AL022393 ±2.0
C3H-type zinc ®nger protein; similar to D, melanogaster muscleblind B protein AF061261 ±2.0
Leucine-rich repeat (in FLII) interacting protein 1 U69609 ±1.9
Ribosomal proteins, 1.1%a, 5%b
Ribosomal protein S6 kinase, 90 kDa, polypeptide 3 U08316 ±1.9
Solute carriers and ionic channels, 6.8%a, 2.4%b
Solute carrier family 16 (monocarboxylic acid transporters), member 6 U79745 ±6.0
Solute carrier family 4, sodium bicarbonate cotransporter, member 7 AF053755 ±2.9
Potassium voltage-gated channel, Shab-related subfamily, member 1 L02842 ±2.9
ATPase H-transporting lysosomal (vacuolar proton pump) b-polypeptide, 56/58 kDa, isoform 1 M25809 ±2.1
Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 AF026132 ±2.1
Solute carrier family 12 (sodium/chloride transporters), member 3 X91220 ±1.9
Receptors/receptors constituents, 4.2%a, 1.3%b
RAN binding protein 2 like-1 AU123973 ±3.1
Thyroid stimulating hormone receptor AF035261 ±2.2
anC (bacterial lantibiotic synthetase component C)-like 1 Y11395 ±1.9
Transcription factors, 2.2%a, 0.4%b
Transcription factor 17 AF116030 ±2.8
Microphthalmia-associated transcription factor AB006909 ±2.7
Tumor suppressors, 2.2%a, 12.5%b
Suppression of tumorigenicity 16 (melanoma differentiation) AW00825 ±2.3
Phosphatase and tensin homolog (mutated in multiple advanced cancers 1) U93051 ±1.9
(Proto)-oncogenes, 2.2%a, 1.4%b
v-kit Hardy±Zuckerman 4 feline sarcoma viral oncogene homolog NM_000222 ±1.9
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog NM_002350 ±1.9
Miscellaneous
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide, Y chromosome AF000984 ±4.2
Serum/glucocorticoid regulated kinase AF153609 ±3.0
Rho-associated, coiled-coil-containing protein kinase 1 NM_005406 ±2.8
Interleukin 6 signal transducer (gp130, oncostatin M receptor) M57230 ±2.7
Ras-GTPase-activating protein SH3-domain-binding protein U32519 ±2.5
Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2 J03603 ±2.3
UDP-glucose ceramide glucosyltransferase AA27855 ±2.2
C-terminal binding protein 2 AF016507 ±2.1
Protein tyrosine phosphatase, nonreceptor type 12 M93425 ±2.1
Interferon gamma-inducible protein 16 AF2080043 ±2.1
Coatomer protein complex, subunit beta AL136593 ±2.0
Apoptosis inhibitor hiap-1 U37546 ±2.0
Adaptor-related protein complex 1, gamma 1 subunit AA993707 ±2.0
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Table III (continued)
Function family GenBank accession number DE
Pre-B-cell colony-enhancing factor NM_005746 ±2.0
Oligophrenin 1 NM_002547 ±2.0
UDP-glucose dehydrogenase AF061016 ±2.0
Fibronectin 1 AW385690 ±2.0
Kinesin family member 5B NM_004521 ±1.9
rab6 GTPase activating protein (GAP and centrosome-associated) AJ011679 ±1.9
Multimerin NM_007351 ±1.9
Mitogen-activated protein kinase kinase kinase 7 AB009357 ±1.9
Cubilin (intrinsic factor-cobalamin receptor) NM_001081 ±1.9
Cerebral cavernous malformations 1 (developmentally downregulated 2) U90268 ±1.9
Rho-associated, coiled-coil-containing protein kinase 2 AB014519 ±1.9
Synaptophysin-like protein BE89139 ±1.9
OVEREXPRESSED KNOWN CLONES
DNA/RNA synthesis and modi®cation, 4.2%a, 1.6%b
Nuclear transcription factor Y, alpha AL031778 +2.2
Forkhead box F1 U13219 +2.0
DNA-binding transcriptional activator NM_006316 +1.9
Ribosomal proteins, 16.9%a, 18.8%b
Ribosomal protein L35 AW410089 +2.2
Ribosomal protein S15 BE409260 +2.0
Ribosomal protein L17 BE274071 +2.0
Ribosomal protein L13a AW245871 +2.0
Ribosomal protein L10 BE622670 +2.0
Ribosomal protein L35 AW393460 +2.0
Laminin receptor 1 (67 kDa, ribosomal protein SA) BF688744 +2.0
Ribosomal protein S14 AV708254 +1.9
Ribosomal protein L28 AU131942 +1.9
Ribosomal protein L19 AW410865 +1.9
Ribosomal protein S23 D14530 +1.9
Ribosomal protein S3A BE207072 +1.9
Solute carriers and ionic channels, 5.6%a, 2.1%b
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (9) isoform 3 BE250803 +2.3
Aquaporin 4 NM_001650 +2.0
arsA (bacterial) arsenite transporter, ATP-binding, homolog 1 NM_004317 +2.0
ATP synthase, H+ transporting, mitochondrial F1 complex, a-subunit, isoform 1, car.mu BE251340 +1.9
Receptors/receptors constituents, 4.5%a, 1.1%b
Laminin receptor 1 (67 kDa, ribosomal protein SA) BF688744 +2.0
Folate receptor 3 (gamma) NM_000804 +1.9
Protein tyrosine phosphatase, receptor type, c polypeptide-associated protein X97267 +1.9
Transcription factors, 2.8%a, 0.2%b
Nuclear transcription factor Y, alpha AL031778 +2.2
DNA-binding transcriptional activator NM_006316 +1.9
Tumor suppressors, 1.4%a, 2.9%b
Ribosomal protein L10 BE622670 +2.0
(Proto)-oncogenes, 1.4%a, 1.0%b
h-pim 1 M54915 +1.9
Miscellaneous
Selenophosphate synthetase 2 NM_012248 +2.6
Plakophilin 1 NM_000299 +2.3
Mannosidase, alpha, class 1A, member 1 NM_000299 +2.2
Tubby like protein 1 AI380477 +2.2
Lectin, galactoside-binding, soluble, 3 (galectin 3) BF18307 +2.2
Interferon-induced, hepatitis-C-associated microtubular aggregate protein (44 kDa) NM_006417 +2.2
G-protein-coupled receptor kinase 5 NM_005308 +2.2
PTD008 protein W04866 +2.1
Syndecan 4 (amphiglycan, ryudocan) X67016 +2.1
Protein tyrosine kinase 6 X78549 +2.1
Lactotransferrin M93150 +2.1
Phosphofructokinase, liver AL041002 +2.1
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (18 kDa, B18) AI199316 +2.0
Proteasome (prosome, macropain) subunit, beta type, 6 BF20529 +2.0
Frizzled (Drosophila) homolog 2 L37882 +2.0
Myosin, light polypeptide 1, alkali; skeletal, fast M31211 +2.0
Glycoprotein Ib (platelet), alpha polypeptide M22403 +2.0
Receptor (calcitonin) activity modifying protein 1 BF206169 +2.0
Mitogen-activated protein kinase 8 interacting protein 2 U79261 +2.0
Adenylate cyclase 9 AI248827 +2.0
Guanylate kinase 1 T36282 +2.0
Calpain 4, small subunit (30K) BE397929 +2.0
Major histocompatibility complex, class I, C AI564701 +2.0
Ubiquitin-conjugating enzyme E2M (homologous to yeast UBC12) AA127782 +1.9
Claudin 7 AI151456 +1.9
Low molecular mass ubiquinone-binding protein (9.5 kDa) AV755812 +1.9
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proteins, the second largest family of known modulated genes,
were essentially overexpressed (16.9%). Solute carriers, porins, and
ionic channels represented 5.6% upregulated and 6.8% repressed
clones. Another important category, cell receptors and receptor
components, represented 4.2% and 4.5% of overexpressed and
underexpressed genes, respectively. Fewer than 3% of the genes
modulated were transcription factors (2.2% and 2.8% of under-
expressed and overexpressed genes, respectively).
Finally, we looked at tumor suppressors and (proto)oncogene
families. Three known tumor suppressor genes and three
oncogenes were modulated > 1.9 times, mainly underexpressed.
Genes responsive to UV stress in NHM display widespread
and preferential chromosome distributions We assessed the
chromosomal distribution of the differentially modulated known
genes (Fig 2). Although all human chromosomes were implicated,
chromosomes 1, 2, 6, 11, 17, and 19 were mainly involved.
Underexpressed genes were frequently on chromosomes 8, 10, 13,
and Y, and overexpressed genes on chromosomes 12, 17, 20, and
X.
Kinetics of expression of four genes modulated upon UV
stress in NHM con®rm the microarray results Kinetics of
expression of two EST and two known genes selected on
microarrays were established over a 24 h period on different sets
of NHM culture, to con®rm microarray data by checking the actual
underexpression or overexpression of the transcripts and to
determine the amplitude of changes. As shown on Fig 3, the
abundance of the serum glucocorticoid regulated kinase (Sk1) and
EST 101B decreased with time, in agreement with microarray data.
The human ribosomal protein L35 (Hrp) showed early increase in
expression followed by a decrease between 6 and 24 h post
irradiation. These observations con®rmed microarray data (2.3
upregulation at 4 h). For EST 406A, a bimodal expression occurred
with two peaks at 2 h and 16 h post irradiation and lowered levels at
8 h and 24 h. The mRNA level was increased at 4 h, however,
again con®rming microarray data. Taken together, these results
show good correlation between microarray and RT-PCR analyses
of expression levels but underscore that microarray analysis only
gives a snapshot of gene expression after a 4 h exposure of NHM to
UV. Although results from this study give valuable indications on
which genes are modulated, kinetics studies are eventually required
to select the most interesting targets for further studies.
Observed modulations by UV of melanocyte gene
expression paralleled previous data obtained for melanoma
with similar platform assay To search for possible relationships
between UV-sensitive genes and genes involved in melanoma, our
data were compared to data of other groups on gene expression in
melanoma. We ®rst considered the work published by Bittner et al
(2000), because a microarray platform (checking »8000 cDNA
clones) similar to ours was employed. These authors analyzed the
expression of a given gene in samples from different patients
(normalized to control cell cultures) that displayed various DE ratio
values: upregulation occurred in some samples whereas
Table III (continued)
Function family GenBank accession number DE
Biliverdin reductase B (¯avin reductase (NADPH)) AW161042 +1.9
Human clone 23815 mRNA sequence AK025583 +1.9
Phosphoglycerate mutase 2 (muscle) BE263723 +1.9
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3 (12 kDa, B12) W07211 +1.9
Ribose 5-phosphate isomerase A (ribose 5-phosphate epimerase) L35035 +1.9
Nonmetastatic cells 4 protein BF342774 +1.9
Spectrin, beta, nonerythrocytic 1 AI580089 +1.9
Myosin, light polypeptide 6, alkali, smooth muscle and nonmuscle AK026164 +1.9
Actin, gamma 1 BF305505 +1.9
Actin-related protein 2/3 complex, subunit 1B (41 kDa) NM_005720 +1.9
Transducin-like enhancer of split 4, homolog of Drosophila E(sp1) AL162059 +1.9
Neurogranin (protein kinase C substrate, RC3) H46727 +1.9
Adenine phosphoribosyltransferase Y00486 +1.9
ATPase, vacuolar, 14 kDa AV711594 +1.9
Triosephosphate isomerase 1 X69723 +1.9
Membrane protein of cholinergic synaptic vesicles L78833 +1.9
Glutathione peroxidase 1 BF237880 +1.9
aPercentage of total of either underexpressed or overexpressed known clones modulated > 1.9 times.
bPercentage of total arrayed clones of that protein function category.
Figure 3. Kinetics of expression of some selected genes in NHM
following the UV stress. Expressions of related transcripts were
monitored over a 24 h period following the acute UV stress in NHM,
using RT-PCR procedures with speci®c primers (see Materials and
Methods). It was checked that PCR ampli®cation was in the linear range
for each transcript. (A) Kinetics of EST 101B and 406A transcripts,
respectively, underexpressed 2.0 times and overexpressed 2.1 times at
4 h, according to microarray data. (B) Kinetics of serum glucocorticoid
kinase (KP Sk1) and the human ribosomal protein L35 (KP Hrp)
transcripts, respectively, underexpressed 3 times and overexpressed 2.3
times at 4 h, according to microarray data. b-actin transcript was not
affected by UV irradiation and served as an internal standard for equal
loading of total RNA.
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downregulation occurred in others. To select for strong DE, we
decided to consider only ratios lower than 0.9 (underexpressed
clones) and higher than 1.1 (overexpressed clones), as the minimum
DE was 0.01. To allow for comparison with our data, the average
modulation of each gene was calculated by summing the number of
patients in which it was overexpressed and subtracting the number
of patients in which it was underexpressed. Results are reported in
Table IV as genes overexpressed (+) or underexpressed (±) in
Table IV. Comparison of melanocyte known genes modulated by UV to genes modulated in melanoma reported by
Bittner et al (2000) shows many related pro®les
Clones This studyb Bittner et alab
Actin-related protein 2/3 complex, subunit 1B (41 kDa) + +
Actin, gamma 1 + +
Adenine phosphoribosyltransferase + +
Adenylate cyclase 9 + +
Apoptosis inhibitor hiap-1 ± ±
Aquaporin 4 + +
arsA (bacterial) arsenite transporter, ATP-binding, homolog 1 + ±
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (9) isoform 3 + +
ATP synthase, H+ transporting, mitochondrial F1 complex, a-subunit, isoform 1, cardiac muscle + +
C3H-type zinc ®nger protein; similar to D, melanogaster muscleblind B protein ± +
Receptor (calcitonin) activity modifying protein 1 + +
Chromodomain helicase DNA binding protein 1 ± +
Coatomer protein complex, subunit beta ± +
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 15 ± ±
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 5 (RNA helicase 68 kDa) ± ±
E74-like factor 1 (ets domain transcription factor) ± ±
Fibronectin 1 ± ±
Guanylate kinase 1 + +
Hypothetical protein P1 p373c6 ± +
Human clone 23815 mRNA sequence + +
Hypoxia-inducible factor 1, alpha subunit (basic helix±loop±helix transcription factor) ± ±
Interferon regulatory factor 2 ± ±
Interferon, gamma-inducible protein 16 ± +
Kinesin family member 5B ± +
Laminin receptor 1 (67 kDa, ribosomal protein SA) + ±
Leucine-rich repeat (in FLII) interacting protein 1 ± +
Major histocompatibility complex, class I, C + ±
Mannosidase, alpha, class 2B, member 1 + +
Mitogen-activated protein kinase kinase kinase 7 ± ±
Multimerin ± ±
Myosin, light polypeptide 1, alkali; skeletal, fast + ±
Myosin, light polypeptide 6, alkali, smooth muscle and nonmuscle + ±
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (18 kDa, B18) + +
Phosphofructokinase, liver + +
Pre-B-cell colony-enhancing factor ± +
Proteasome (prosome, macropain) subunit, beta type, 6 + ±
Protein tyrosine phosphatase, nonreceptor type 12 ± ±
Protein tyrosine phosphatase, receptor type, c polypeptide-associated protein + +
RAN binding protein 2 like 1 ± 1c
Ras-GTPase-activating protein SH3-domain-binding protein ± +
Ribose 5-phosphate isomerase A (ribose 5-phosphate epimerase) + +
Ribosomal protein L10 + +
Ribosomal protein L19 + +
Ribosomal protein L28 + ±
Ribosomal protein S14 + +
Ribosomal protein S23 + ±
Ribosomal protein S6 kinase, 90 kDa, polypeptide 3 ± ±
Serum/glucocorticoid regulated kinase ± +
Solute carrier family 12 (sodium/chloride transporters), member 3 ± ±
Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 ± +
SON DNA binding protein ± ±
Suppression of tumorigenicity 16 (melanoma differentiation, ST16) ± +
Syndecan 4 (amphiglycan, ryudocan) + +
Transducin-like enhancer of split 4, homolog of Drosophila E(sp1) + ±
Translin-associated factor X ± ±
UDP-glucose ceramide glucosyltransferase ± +
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog ± +
Zinc ®nger protein 184 (Kruppel-like) ± ±
Zinc ®nger protein 38 (KOX 25) ± ±
Zinc ®nger protein 7 (KOX 4, clone HF.16) ± +
aBittner et al (2000).
b+, ±,overexpressed and underexpressed clones, respectively. Clones are listed in alphabetic order.
cNumber of patients with gene overexpression equals number of patients with gene underexpression (i.e., ratio is 1).
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melanoma. Due to differences in microarray spotting, only 61 out
of 159 UV-modulated known genes could be retrieved in both
platforms and compared for expression in melanoma. Nineteen out
of 29 (65.5%) of UV-upregulated transcripts were also upregulated
in melanoma cells. Seventeen out of 32 (53.1%) of UV-
downregulated transcripts were also repressed in melanoma cells.
Altogether, 59% of the UV-sensitive known genes detected by our
microarray analysis were modulated in the same way in melanoma.
We tried then to parallel our microarray data with those of two
other studies that determined a list of genes speci®cally regulated in
melanoma (Table V). They both used different methodologies and
platforms. Clark et al (2000) used an oligonucleotide array platform
to select genes that were overexpressed in the instrumentally forced
metastatic phenotype of human melanoma cells A375P when
injected in nude mice. Eight out of the 23 upregulated transcripts
were present in our microarray. Three were slightly overexpressed
after UV irradiation of melanocytes as detected by our microarray
analyses, but at a threshold < 1.4, which represented the lower
limit of DE signi®cance (1.4 6 0.12, see Materials and Methods).
Three others were found rather downregulated in our study, but
only one, ®bronectin, at a signi®cant level (DE = ±2.0) as the others
displayed DE values < 1.4. On the whole, except for ®bronectin, it
is likely that such expression ¯uctuations were not signi®cant,
suggesting absence of correlation between UVB-modulated genes
in melanocytes and those modulated in Clark et al's study. It is
noteworthy that Clark et al's data do not match those of Bittner et al
either (Table V).
Finally, in Table V we report the genes present in our
microarray platform that were found preferentially expressed in
melanoma tumors by Hipfel et al (2000). These authors used the
methodology of (PCR-based) subtractive hybridization (between
melanoma tumors and benign melanocytic tumors). They em-
ployed a macroarray of the differentially expressed clones for
further screening with melanoma tissue (or nevi) probes. Only two
upregulated genes out of the 18 determined in that study were
found slightly overexpressed in our investigation, but at a DE
threshold < 1.4, not signi®cant. Again, Hipfel et al's data showed
poor correlation with those of Bittner et al with only one matching
overexpressed clone (Table V).
Variable expression of two selected EST clones in human
melanoma cell lines and tumors To look for possible links
between UV stress and melanocarcinogenesis, preliminary
experiments were designed to check for expression of EST 101B
and 406A in four melanoma cell lines (KAL, HBL, SK-MEL-2,
M3Dau) and in eight tumors from patients with different
melanoma clinical features, as shown in Table I. These EST
were chosen because they were expressed at relatively high levels
and displayed opposite modulations. EST 101B and EST 406A
were found expressed in all melanoma cell lines, although at
different levels (Fig 4A). EST 101B was strongly expressed in HBL
cells and only at low levels in KAL line. EST 406A was more
strongly expressed in SK-MEL-2 cells than in M3Dau cells.
EST E101B was expressed in some melanoma to different levels,
whereas EST 406 A was always expressed from low to very high
levels (tumors 1, 4, 7, Fig 4B). No correlation was observed
between expression of these transcripts and melanoma stages, as T3
and T4 were primary tumors, T1, T5, T6 local secondary tumors
and T2, T7, T8 distant lymph node metastases.
Figure 4. Expression of EST 101B and 406A related transcripts in
human melanoma cell lines and tumors. Expressions of EST 101B
and 406A related transcripts were determined in KAL, HBL, SK-MEL-2
(SK2), and M3Dau human melanoma cell lines (A) as well as in
melanoma tumors (B), using RT-PCR procedures with speci®c primers.
T1, T5, T6 were secondary tumors; T3 and T4 primary tumors; T2, T7,
and T8 distant secondary tumors from lymph node metastases.
Table V. Comparison of genes with modi®ed expression in melanoma detected by different platform assays (Bittner et al,
2000; Clark et al, 2000; Hipfel et al, 2000) and UV-modulated genes detected with our microarray platform shows marked
discrepancies and few similarities
Clones This studya Bittner et alab Clark et alac Hipfel et ald
Angiopoietin 1 ±(*) +
Catenin (cadherin-associated protein), alpha 2 (E) ±(*) +
CD59 antigen p18±20 (antigen identi®ed by monoclonal antibodies
16.3A5, EJ16, EJ30, EL32, and G344)
+(*) + e.p.
Fibromodulin +(*) 1 +
Fibronectin 1 ± ± +
Heat shock protein 70 (Hsp70) 1 +
Homo sapiens MSH55 gene, partial cds; and CLIC1, DDAH, G6b, G6c,
G5b, G6d, G6e, G6f, BAT5, G5b, CSK2B, BAT4, G4, Apo M, BAT3,
BAT2, AIF-1, 1C7, LST-1, LTB, TNF, and LTA genes, complete cds
+(*) ± e.p.
KIAA0156 gene product +(*) ± +
Matrix Gla protein 1 +
Valosin-containing protein +(*) +
a+, ±, overexpressed and underexpressed clones, respectively. 1, no modulation; (*), DE < 1.9. Clones are listed in alphabetic order.
bBittner et al (2000).
cClark et al (2000).
dHipfel et al (2000). e.p., expressed preferentially.
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DISCUSSION
Using a DNA microarray technology applied to more than 9000
human genes, this study provides an expression pattern of NHM
genes 4 h after an acute UV stress. UV-induced modulations were
compared to modulations observed in melanoma by other inves-
tigators. Cultured cells were irradiated once at a ¯uence of 100 mJ
per cm2 with mercury vapor lamps, which provided mainly UVB
radiation. Obviously, these conditions do not match exactly the
in vivo situation, especially with regard to sun exposure modalities
and spectral irradiances in humans. A careful interpretation of data
from studies using arti®cial UV sources is required (Gasparro and
Brown, 2000). In fact, epidemiologic studies suggest that an intense
sun exposure leading to sunburn in the early years of life is the ®rst
step that triggers changes in melanocytes towards possible malignant
transformation (Elwood, 1996; DoreÂ et al, 2001). In this investi-
gation, a single UV irradiation of NHM in culture was chosen to
approximate such minimum step. This approach could provide a
list of sensitive genes useful for further re®ned molecular investi-
gations that may consider the action spectrum of the light source
(i.e., the wavelength dependence of the biologic effect, such as the
induction of gene expression).
Another common dif®culty with cultured cells is to take into
account the notion of skin phototype and related (just perceptible)
minimal erythema dose (MED) (Farr and Diffey, 1985). Rather, the
biologically ef®cient dose (BED) should be substituted for MED in
the absence of vasculature (Bernerd and Asselineau, 1997). In our
investigation, the choice of 100 mJ per cm2 ¯uence at 312 nm was
based on the compilation of several photodermatology and in vitro
cutaneous cell biology reports, and by assessing NHM viability with
UV dose±response curves. Young et al (1998) have evaluated for
several wavelengths a median MED (just perceptible minimal
erythema dose) in patient populations of skin phototypes I and II.
MED were 250 and 2400 mJ per cm2 at UVB wavelengths 310 and
320 nm, respectively. They correspond thus to ¯uences higher than
that of our study, which is also in the working range used by many
investigators (see for instance Bernerd and Asselineau, 1997; Vogt et
al, 1997; Shimizu et al, 1999; Becker et al, 2001). In addition, in our
study, a ¯uence of 100 mJ per cm2 UV at 312 nm allowed >75%
NHM viability 15 h after UV irradiation, demonstrating that it was
not drastically harmful (data not shown).
The 4 h period of time chosen before collecting mRNAs for our
microarray procedure was considered as an intermediate time-point
of cell response to UV exposure. In fact, we wished to limit the
selection of genes of ``immediate early responses'' and of (late)
apoptotic pathways. Many ``early response genes'' (such as c-fos),
which are known to be modulated by UV radiation, do not display
a strict speci®city with regard to cell stress inducers such as growth
factors (epidermal growth factor) and tumor promoting drugs
(PMA). On the other hand, genes involved in tissue or tumor cell
death, which operate in melanoma tumors, are supposedly not
involved in primary events of melanocarcinogenesis when tumors
are not formed. The choice of an intermediate time-point
corresponding to 4 h post irradiation is supported by data from
the literature (Garmyn et al, 1991). For example, in human
keratinocytes, transcript levels of c-Jun N-terminal kinase-1
(JNK1), c-jun, and c-fos peak 30 min after UV exposure (Assefa
et al, 1997), whereas transcripts of tumor necrosis factor a and
macrophage migration inhibitory factor are maximally expressed 4±
6 h after UV irradiation (Leverkus et al, 1998; Shimizu et al, 1999).
In melanocytes, Vogt et al (1997) de®ned as late-transcribed, genes
modulated 8 h after treatment with UVB. In the absence of further
information on the kinetics of gene modulation after UV
treatment, the choice of a 4 h exposure will give a snapshot of
the situation in mid process. Subsequent RT-PCR analyses will
also provide indications on the actual expression level of any gene
at other time-points of interest.
This study establishes that 198 genes (2.2% of the total spotted on
the DNA microarray) were modulated at least 1.9 times in UV-
irradiated NHM compared to control sham-irradiated NHM. To
control the quality of data obtained from microarray analysis, four
genes were randomly chosen among the modulated ones and their
expression levels were monitored during 0±24 h post irradiation by
RT-PCR. No discrepancy was observed at the 4 h time-point,
suggesting that microarray analysis provides reliable results.
A majority of transcripts (59.1%) were underexpressed. Among
the 198 modulated genes, 39 were EST, corresponding to genes
awaiting structural and functional characterization. Although we do
not know whether the identi®ed genes are causally linked to
melanocytic transformation, it is likely that some of them are
collectively involved in (photo-induced) melanocarcinogenesis and
UV resistance of cutaneous melanocytes. This is suggested ®rstly by
changes in mRNA levels of some known clones that correspond to
important genes for pigment cell formation and function (KIT,
MITF, MDA-7) (Loftus and Pavan, 2000) and to candidate
melanoma loci (PTEN/chromosome 10q, chromosome 1 and 6)
(Castellano and Parmiani, 1999). In addition, the comparison of
UV-modulated genes selected by microarray to published gene
expression pro®les in melanoma shows that many of them undergo
modi®cation of their expression in the disease. The best match
occurred with data from Bittner et al (2000), which employed a
similar methodology and DNA microarray platform. Fifty-nine
percent of known genes modulated by UV have their expression
modi®ed in the same way in melanoma samples.
Our attempt to parallel melanoma gene expression pro®les from
three published works (Bittner et al, 2000; Clark et al, 2000; Hipfel
et al, 2000) was laborious and elicited marked discrepancies. The
®rst problem is that the collections of genes screened are not similar
from study to study. Also, lack of standardization of the results from
various microarray platforms impairs the relevance of such
comparisons when different methodologies are used. Such a
complex problem has not been satisfactory managed yet (Bassett
et al, 1999; Brazma and Vilo, 2000). As a consequence, information
is lost, and unexplained contradictory results may occur (see
examples in Clark et al, 2000; Hipfel et al, 2000). These dif®culties
applied when we wanted to compare the UV-sensitive known
genes depicted by our microarray with those already known to be
modulated by UVB. For instance, after UVB exposure, bcl-2
protein, which was found in NHM either upregulated (Kim et al,
2000) or downregulated (Im et al, 1998), or displaying unchanged
transcript levels in transformed cell lines from melanoma patients
(Shannon et al, 2001), was absent from our microarray and
comparison of data was not possible. This also applied to the
melanogenesis enzyme tyrosinase, whereas the tyrosinase-related
protein 1 (TRP-1), whose cDNA was spotted on our microarray,
displayed unchanged transcript level after UV stress (DE = 1.1)
(data not shown). Other studies have reported that TRP-1
underwent either no change in protein levels (Abdel-Malek et al,
1994) or overexpression of related mRNA (and protein) after
repeated exposures of UVB (Jimbow et al, 1994) that could be
dependent on p53 (Nylander et al, 2000). Among the tumor
suppressors that were described to accumulate (and mutate) after
UV irradiation of melanocytes, p16INK4a (Castellano and Parmiani,
1999; Piepkorn, 2000b) and p53 (Barker et al, 1995; Medrano et al,
1995) were represented on our microarray. None of them,
however, displayed signi®cant variation (+1.2 and ±1.3 DE,
respectively). Previous observations showing that radiation dose
and cell type determine the pattern of transcription responses might
explain these discrepancies. In melanocytes, for instance, higher
doses of UVB (>30±40 mJ per cm2) result in low subsequent p53
cell levels, contrary to lower doses (Kim et al, 2000; Shannon et al,
2001), and p16INK4a upregulation was reported with UVB ¯uences
lower than 20 mJ per cm2 only (Piepkorn, 2000b).
Our DNA microarray analysis shows that an overwhelming
majority of UV-modulated known clones corresponded to DNA
or RNA binding, synthesis, or modi®cation proteins and were
mainly underexpressed. Transcription factors were either under-
expressed or overexpressed. These observations underline the direct
in¯uence of UV on gene expression, in addition to potential UV
induction of genetic instability through DNA damage and
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alterations of DNA repair mechanisms. This strengthens the
hypothesis that genes potentially involved in melanocarcinogenesis
are present among known genes and EST selected by our
microarray analysis. An example to support this idea is the
modulation of the microphthalmia-associated transcription factor
(Mitf, underexpressed 2.7 times), which has been proposed to be a
possible prognostic marker of melanoma (Goding, 2000; Salti et al,
2000) and which is repressed in melanoma cell lines (Vachtenheim
and Novotna, 1999).
Another important point is that many UV-modulated known
clones encode ribosomal proteins. These proteins are involved in
protein synthesis, which is required to maintain cell homeostasis
and survival, but some of them could also regulate proliferation and
cell death (Chen and Ioannou, 1999). Overexpression of ribosomal
proteins in transformed phenotypes has already been reported (Go
and Taniguchi, 1998), especially in melanoma (Santa Cruz et al,
1997; Kocher et al, 2000). They did not include proteins selected in
this study, suggesting that studies on the potential link between
ribosomal proteins and UV-induced melanocarcinogenesis should
be extended.
Tumor suppressor genes and (proto)oncogenes were also
modulated in UV-irradiated NHM, particularly PTEN, ST16/
mda-7, and v-kit. Although their involvement in melanoma
remains controversial, recent reports suggest that they participate in
melanoma initiation and progression, at least in some forms of the
disease (Jiang et al, 1995; Castellano and Parmiani, 1999; Celebi et
al, 2000; Piepkorn, 2000a; Bar-Eli, 2001).
UV radiation in NHM also modulated several receptors that
could play a role in melanoma progression. Of these, the 67 kDa
laminin receptor (Vacca et al, 1993), which was overexpressed 2
times, has been involved in tumoral invasion. The treatment of
melanoma cells with peptide G, a synthetic peptide that contains
the laminin-binding domain of the 67 kDa laminin receptor, results
in augmentation in vivo of mouse lung metastases (Taraboletti et al,
1993).
The chromosomal assignment performed on known genes that
were modulated by UV showed that all human chromosomes bore
UV-stressed genes, but that chromosomes 1, 2, 6, 11, 17, and 19
were mainly concerned. Although still largely debated, it is
noteworthy that currently available literature reports that chromo-
somes 1, 6, and 11 harbor abnormalities in some forms of
melanoma, especially the familial form (Castellano and Parmiani,
1999; Piepkorn, 2000a). A locus was ®rst identi®ed on chromo-
some 1p (1p36) in genetic linkage with melanoma in a familial
subset of the disease (Bale et al, 1989). The ®nding was based on
previous observations that frequent loss of heterozygosity (LOH)
detected by restriction fragment length polymorphism analyses
occurred in this region (Dracopoli et al, 1985). Nevertheless, since
the 1990s, several studies have challenged these data, because it
appeared that 1p36 was linked with cutaneous melanoma±dysplastic
nevus syndrome rather than with cutaneous melanoma alone
(Piepkorn, 2000a). Of course, this cannot exclude the possibility
that 1p36, and other sites on chromosome 1, may house
susceptibility loci for initial (photo-induced) steps of melanocarci-
nogenesis. This is suggested by the involvement of 1p36 genes such
as the neuroblastoma suppressor of tumorigenicity-1 and the cell
division cycle 2-like 1 (PITSLRE proteins) in cell transformation.
The latter in particular are especially relevant to melanoma (Nelson
et al, 1999). Although in our microarray analysis they were
excluded from the selected genes at the DE threshold chosen, cell
division cycle 2-like 1 was upregulated 1.5 times and neuroblas-
toma suppression of tumorigenicity-1 was upregulated 1.8 times
(data not shown). This gives evidence for their relative sensitivity to
UV stress, as DE was close to the limit of signi®cance (1.4±1.5 DE).
Among selected genes mapping to chromosome 1 that were
modulated by UV radiation, plakophilin 1 (DE = +2.3) and ST16/
mda-7 (DE = ±2.3) have been involved in nonmelanoma and
melanoma cutaneous cancers, respectively (Jiang et al, 1995; Moll et
al, 1997; Villaret et al, 2000).
Chromosome 6, which harbors several UV-modulated genes
detected by our microarray analysis, has been involved in sporadic
melanomas through cytogenetic alterations and LOH in 6q
(Millikin et al, 1991; Walker et al, 1994; Thompson et al, 1995).
Although the MYB oncogene maps to the 6q15±q23 region where
translocations and deletions occur in some melanoma patients,
candidate genes have not yet been identi®ed. In this regard, the
strongly underexpressed serum/glucocorticoid regulated kinase
gene (DE = ±3.0) revealed by our DNA microarray analysis,
which locates in 6q23, might be of special interest. In addition,
although previously reported links of chromosome 6p locus to
melanoma have been discredited by many subsequent studies, it is
noteworthy that many UV-modulated genes map to this locus. Of
these, zinc ®nger protein 184 (Kruppel-like) (DE = ±3.0), nuclear
transcription factor Y-alpha (DE = +2.2), and major histocompat-
ibility complex, class I, C (DE = +2.0) were all located in 6p21.3.
LOH studies and chromosome transfer experiments to microcells
demonstrated the involvement of chromosome 11q locus in
melanoma (Castellano and Parmiani, 1999). Two UV-modulated
genes map to this locus: the heat shock 27 kDa protein 2
(DE = 2.6) in 11q22±q23, where LOH occurs in 30% of sporadic
melanoma tumors, and the desmoyokin (DE = ±2.0) in 11q12±q13
whose status has not been de®ned yet in melanoma. Further studies
may be aimed at unravelling the possible links of these potential
candidate genes to melanocarcinogenesis.
Finally, we would like to underscore the relationships of UV-
modulated known genes and three other genomic melanoma
hotspots de®ned by LOH on chromosomes 3p, 9p, and 10q
(Castellano and Parmiani, 1999; Piepkorn, 2000a). Indeed, as
mentioned previously, two UV-modulated genes involved in
melanoma, Mitf (DE = ±2.7) and laminin receptor/67 kDa/
ribosomal protein SA (DE = +2.0), map to regions 3p14.1±p12.3
and 3p21.3, respectively. It should thus be interesting to determine
whether they could also be candidate genes in melanoma photo-
initiation. The LOH region in sporadic melanoma localized in
10q23 correlating with tumor progression has led to the discovery
of a candidate tumor suppressor gene, PTEN (10q23.3), which is
altered in many melanomas. PTEN was found underexpressed 1.9
times in our microarray, indicating that the locus might also be
linked to early events of UV-induced melanoma. Additionally,
positional cloning allowed mapping of the p16INK4a gene in the
9p21±22 region found in linkage with 50% melanoma-prone
families and involved in a high percentage of sporadic melanoma.
The p16INK4a gene was not responsive to UV in our microarray,
however, suggesting that it might not be involved in early events of
photo-induced melanoma. Further studies aimed at better
characterizing the links of genetic regions (and candidate genes)
mentioned in this paper with UV stress and melanoma features
might be of interest for molecular-based prediction of risk of the
disease.
Identi®cation of several unknown genes, de®ned by their EST,
that are responsive to UV stress is also important information. They
present both a basic biologic interest, as they are probably involved
in the pathophysiology of melanocytic cells (and perhaps of other
cells, such as neurons that share a common embryonic origin), and
a clinical interest, as some of them could be important as
melanocarcinogenesis and/or melanoma progression markers. In a
preliminary set of experiments, we monitored the expression of
EST 101B and EST 406A in several melanoma tumors, from
primary to distant metastases. Interestingly, they were differentially
expressed but expression did not correlate with tumor stage. They
deserve being characterized further, by determining their coding
sequences and looking at their biologic function in normal and
tumoral melanocytic cells. Analyzing the expression levels of EST
identi®ed in this microarray study in a larger number of melanoma
tumors might lead to discovery of potential markers of melano-
carcinogenesis and melanoma progression.
Finally, the list of NHM UV-sensitive genes de®ned in this
investigation could be pro®table for future expression pro®ling
experiments on various melanocytic tumors (such as nevi) accord-
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ing to speci®c phenotypes and sun exposure background of
patients. Mathematical gene expression cluster analyses of data, as
well as determination of possible nucleotide polymorphisms in the
UV- sensitive EST/genes and their use in linkage analyses, are
promising for further molecular prediction of melanoma risk in
patients (Bittner et al, 2000; Marx, 2000).
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